A true bifurcational stenosis treated with a bioresorbable vascular scaffold and a drug-eluting metallic stent: Degradable meets durable.
The role of bioresorbable scaffolds (BRS) has mostly been investigated in simple coronary lesions. True bifurcational stenoses are one of the major challenges in interventional cardiology. We report here a successful case of a hybrid approach using a bioresorbable scaffold and a drug-eluting metallic stent to treat a true bifurcational lesion. Due to the degradable character of the BRS, only one metallic stent remains and thus the risk of restenosis can possibly be reduced. © 2015 Wiley Periodicals, Inc.